loading

Cocrystal Pharma Inc Azioni (COCP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
9.95%
2.108
2.341 3.23 5.042 5.448
Depreciation and Amortization
16.00%
0.021
0.025 0.028 0.03 0.033
Operating Income/Loss
9.95%
-2.108
-2.341 -3.23 -5.042 -5.448
Nonoperating Income/Loss
32.50%
0.053
0.04 -0.036 0.103 0.105
Income/Loss From Continuing Operations Before Tax
10.69%
-2.055
-2.301 -3.266 -4.939 -5.343
Income/Loss From Continuing Operations After Tax
10.69%
-2.055
-2.301 -3.266 -4.939 -5.343
Net Income/Loss
10.69%
-2.055
-2.301 -3.266 -4.939 -5.343
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
10.17
10.17 - 10.17 10.17
Diluted Average Shares
0.00%
10.17
10.17 - 10.17 10.17
Basic Earnings Per Share
13.04%
-0.20
-0.23 -0.32 -0.49 -0.53
Diluted Earnings Per Share
13.04%
-0.20
-0.23 -0.32 -0.49 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.69
price up icon 0.99%
$28.95
price up icon 0.78%
$102.09
price up icon 0.72%
$104.29
price up icon 0.32%
biotechnology ONC
$310.48
price down icon 0.48%
$183.67
price down icon 1.23%
Capitalizzazione:     |  Volume (24 ore):